PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens
Iain MacLeod et al. develop the Pan-Degenerate Amplification and Adaptation (PANDAA) point mutation assay to detect HIV drug resistance mutations. This method can be applied to any pathogen where target-proximal genetic variability hinders diagnostic development.
Enregistré dans:
Auteurs principaux: | Iain J. MacLeod, Christopher F. Rowley, M. Essex |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f79a51c5dc574d0197305537b3b9d5a5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evaluation validation of a qPCR curve analysis method and conventional approaches
par: Yashu Zhang, et autres
Publié: (2021) -
Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping
par: Baowei Li, et autres
Publié: (2021) -
Laboratory Exercise to Measure Plasmid Copy Number by qPCR
par: Benjamin David, et autres
Publié: (2021) -
Comparison of three qPCR-based commercial tests for detection of periodontal pathogens
par: Fridus Van der Weijden, et autres
Publié: (2021) -
Selection of stable reference genes for RT-qPCR in Rhodococcus opacus PD630
par: Drew M. DeLorenzo, et autres
Publié: (2018)